Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post‐liver transplantation recurrence
Poordad, Fred, Schiff, Eugene R., Vierling, John M., Landis, Charles, Fontana, Robert J., Yang, Rong, McPhee, Fiona, Hughes, Eric A., Noviello, Stephanie, Swenson, Eugene S.
Published in Hepatology (Baltimore, Md.) (01.05.2016)
Published in Hepatology (Baltimore, Md.) (01.05.2016)
Get full text
Journal Article
All‐oral 12‐week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY‐3 phase III study
Nelson, David R., Cooper, James N., Lalezari, Jacob P., Lawitz, Eric, Pockros, Paul J., Gitlin, Norman, Freilich, Bradley F., Younes, Ziad H., Harlan, William, Ghalib, Reem, Oguchi, Godson, Thuluvath, Paul J., Ortiz‐Lasanta, Grisell, Rabinovitz, Mordechai, Bernstein, David, Bennett, Michael, Hawkins, Trevor, Ravendhran, Natarajan, Sheikh, Aasim M., Varunok, Peter, Kowdley, Kris V., Hennicken, Delphine, McPhee, Fiona, Rana, Khurram, Hughes, Eric A.
Published in Hepatology (Baltimore, Md.) (01.04.2015)
Published in Hepatology (Baltimore, Md.) (01.04.2015)
Get full text
Journal Article
Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): Designing Master Protocols for Evaluation of Candidate COVID-19 Therapeutics
LaVange, Lisa, Adam, Stacey J, Currier, Judith S, Higgs, Elizabeth S, Reineck, Lora A, Hughes, Eric A, Read, Sarah W
Published in Annals of Internal Medicine (01.09.2021)
Published in Annals of Internal Medicine (01.09.2021)
Get full text
Journal Article
Web Resource
All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study
Manns, Michael, Prof, Pol, Stanislas, Prof, Jacobson, Ira M, Prof, Marcellin, Patrick, Prof, Gordon, Stuart C, Prof, Peng, Cheng-Yuan, MD, Chang, Ting-Tsung, Prof, Everson, Gregory T, Prof, Heo, Jeong, Prof, Gerken, Guido, Prof, Yoffe, Boris, Prof, Towner, William J, MD, Bourliere, Marc, MD, Metivier, Sophie, MD, Chu, Chi-Jen, MD, Sievert, William, Prof, Bronowicki, Jean-Pierre, Prof, Thabut, Dominique, Prof, Lee, Youn-Jae, Prof, Kao, Jia-Horng, Prof, McPhee, Fiona, PhD, Kopit, Justin, PhD, Mendez, Patricia, MD, Linaberry, Misti, MPH, Hughes, Eric, MD, Noviello, Stephanie, MD
Published in The Lancet (British edition) (01.11.2014)
Published in The Lancet (British edition) (01.11.2014)
Get full text
Journal Article
Daclatasvir in Combination With Asunaprevir and Beclabuvir for Hepatitis C Virus Genotype 1 Infection With Compensated Cirrhosis
Muir, Andrew J, Poordad, Fred, Lalezari, Jacob, Everson, Gregory, Dore, Gregory J, Herring, Robert, Sheikh, Aasim, Kwo, Paul, Hézode, Christophe, Pockros, Paul J, Tran, Albert, Yozviak, Joseph, Reau, Nancy, Ramji, Alnoor, Stuart, Katherine, Thompson, Alexander J, Vierling, John, Freilich, Bradley, Cooper, James, Ghesquiere, Wayne, Yang, Rong, McPhee, Fiona, Hughes, Eric A, Swenson, E. Scott, Yin, Philip D
Published in JAMA : the journal of the American Medical Association (05.05.2015)
Published in JAMA : the journal of the American Medical Association (05.05.2015)
Get full text
Journal Article
Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus–infected patients
Susser, Simone, Welsch, Christoph, Wang, Yalan, Zettler, Markus, Domingues, Francisco S., Karey, Ursula, Hughes, Eric, Ralston, Robert, Tong, Xiao, Herrmann, Eva, Zeuzem, Stefan, Sarrazin, Christoph
Published in Hepatology (Baltimore, Md.) (01.12.2009)
Published in Hepatology (Baltimore, Md.) (01.12.2009)
Get full text
Journal Article
Case report of successful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C after liver retransplantation
Fontana, Robert J., Hughes, Eric A., Appelman, Henry, Hindes, Robert, Dimitrova, Dessislava, Bifano, Marc
Published in Liver transplantation (01.09.2012)
Published in Liver transplantation (01.09.2012)
Get full text
Journal Article
Daclatasvir Plus Peginterferon and Ribavirin Is Noninferior to Peginterferon and Ribavirin Alone, and Reduces the Duration of Treatment for HCV Genotype 2 or 3 Infection
Dore, Gregory J, Lawitz, Eric, Hézode, Christophe, Shafran, Stephen D, Ramji, Alnoor, Tatum, Harvey A, Taliani, Gloria, Tran, Albert, Brunetto, Maurizia R, Zaltron, Serena, Strasser, Simone I, Weis, Nina, Ghesquiere, Wayne, Lee, Samuel S, Larrey, Dominique, Pol, Stanislas, Harley, Hugh, George, Jacob, Fung, Scott K, de Lédinghen, Victor, Hagens, Peggy, McPhee, Fiona, Hernandez, Dennis, Cohen, David, Cooney, Elizabeth, Noviello, Stephanie, Hughes, Eric A
Published in Gastroenterology (New York, N.Y. 1943) (01.02.2015)
Published in Gastroenterology (New York, N.Y. 1943) (01.02.2015)
Get full text
Journal Article
Accelerating Coronavirus Disease 2019 Therapeutic Interventions and Vaccines-Selecting Compounds for Clinical Evaluation in Coronavirus Disease 2019 Clinical Trials
Buchman, Timothy G, Draghia-Akli, Ruxandra, Adam, Stacey J, Aggarwal, Neil R, Fessel, Joshua P, Higgs, Elizabeth S, Menetski, Joseph P, Read, Sarah W, Hughes, Eric A
Published in Critical care medicine (01.11.2021)
Published in Critical care medicine (01.11.2021)
Get more information
Journal Article
Overview of ACTIV trial-specific lessons learned
Draghia-Akli, Ruxandra, Read, Sarah W., Hughes, Eric A.
Published in Journal of clinical and translational science (01.01.2024)
Published in Journal of clinical and translational science (01.01.2024)
Get full text
Journal Article
Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial
Pol, Stanislas, Dr Prof, Ghalib, Reem H, Prof, Rustgi, Vinod K, Prof, Martorell, Claudia, Prof, Everson, Greg T, Prof, Tatum, Harvey A, Prof, Hézode, Christophe, Prof, Lim, Joseph K, Prof, Bronowicki, Jean-Pierre, Prof, Abrams, Gary A, Prof, Bräu, Norbert, Prof, Morris, David W, Prof, Thuluvath, Paul J, Prof, Reindollar, Robert W, Prof, Yin, Philip D, MD, Diva, Ulysses, PhD, Hindes, Robert, MD, McPhee, Fiona, PhD, Hernandez, Dennis, PhD, Wind-Rotolo, Megan, PhD, Hughes, Eric A, MD, Schnittman, Steven, MD
Published in The Lancet infectious diseases (01.09.2012)
Published in The Lancet infectious diseases (01.09.2012)
Get full text
Journal Article
Daclatasvir plus simeprevir with or without ribavirin for the treatment of chronic hepatitis C virus genotype 1 infection
Zeuzem, Stefan, Hézode, Christophe, Bronowicki, Jean-Pierre, Loustaud-Ratti, Veronique, Gea, Francisco, Buti, Maria, Olveira, Antonio, Banyai, Tivadar, Al-Assi, M. Tarek, Petersen, Joerg, Thabut, Dominique, Gadano, Adrian, Pruitt, Ronald, Makara, Mihály, Bourlière, Marc, Pol, Stanislas, Beumont-Mauviel, Maria, Ouwerkerk-Mahadevan, Sivi, Picchio, Gaston, Bifano, Marc, M Phee, Fiona, Boparai, Navdeep, Cheung, Kin, Hughes, Eric A, Noviello, Stephanie
Published in Journal of hepatology (01.02.2016)
Published in Journal of hepatology (01.02.2016)
Get full text
Journal Article
Single-Dose Pharmacokinetics of Boceprevir in Subjects with Impaired Hepatic or Renal Function
Treitel, Michelle, Marbury, Thomas, Preston, Richard A, Triantafyllou, Ilias, Feely, William, O'Mara, Edward, Kasserra, Claudia, Gupta, Samir, Hughes, Eric A
Published in Clinical pharmacokinetics (01.09.2012)
Published in Clinical pharmacokinetics (01.09.2012)
Get full text
Journal Article
Short‐duration treatment for chronic hepatitis C virus with daclatasvir, asunaprevir, beclabuvir and sofosbuvir (FOURward study)
Sulkowski, Mark S., Flamm, Steve, Kayali, Zeid, Lawitz, Eric J., Kwo, Paul, McPhee, Fiona, Torbeyns, Anne, Hughes, Eric A., Swenson, Eugene S., Yin, Philip D., Linaberry, Misti
Published in Liver international (01.06.2017)
Published in Liver international (01.06.2017)
Get full text
Journal Article
Randomized comparison of daclatasvir + asunaprevir versus telaprevir + peginterferon/ribavirin in Japanese hepatitis C virus patients
Kumada, Hiromitsu, Suzuki, Fumitaka, Suzuki, Yoshiyuki, Toyota, Joji, Karino, Yoshiyasu, Chayama, Kazuaki, Kawakami, Yoshiiku, Fujiyama, Shigetoshi, Ito, Takayoshi, Itoh, Yoshito, Tamura, Etsuko, Ueki, Tomoko, Ishikawa, Hiroki, Hu, Wenhua, McPhee, Fiona, Linaberry, Misti, Hughes, Eric
Published in Journal of gastroenterology and hepatology (01.01.2016)
Published in Journal of gastroenterology and hepatology (01.01.2016)
Get full text
Journal Article
A randomized trial of daclatasvir with peginterferon alfa-2b and ribavirin for HCV genotype 1 infection
Suzuki, Fumitaka, Toyota, Joji, Ikeda, Kenji, Chayama, Kazuaki, Mochida, Satoshi, Hayashi, Norio, Ishikawa, Hiroki, Miyagoshi, Hidetaka, Hu, Wenhua, McPhee, Fiona, Hughes, Eric A, Kumada, Hiromitsu
Published in Antiviral therapy (01.01.2014)
Published in Antiviral therapy (01.01.2014)
Get full text
Journal Article
Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1
Jacobson, Ira, Zeuzem, Stefan, Flisiak, Robert, Knysz, Brygida, Lueth, Stefan, Zarebska-Michaluk, Dorota, Janczewska, Ewa, Ferenci, Peter, Diago, Moises, Zignego, Anna Linda, Safadi, Rifaat, Baruch, Yaacov, Abdurakhmanov, Dzhamal, Shafran, Stephen, Thabut, Dominique, Bruck, Rafael, Gadano, Adrian, Thompson, Alexander James, Kopit, Justin, McPhee, Fiona, Michener, Tracy, Hughes, Eric A, Yin, Philip D, Noviello, Stephanie
Published in World journal of gastroenterology : WJG (28.03.2016)
Published in World journal of gastroenterology : WJG (28.03.2016)
Get full text
Journal Article
Pharmacokinetic Interactions Between the Hepatitis C Virus Protease Inhibitor Boceprevir and Ritonavir-Boosted HIV-1 Protease Inhibitors Atazanavir, Darunavir, and Lopinavir
Hulskotte, Ellen G. J., Feng, Hwa-Ping, Xuan, Fengjuan, van Zutven, Marga G. J. A., Treitel, Michelle A., Hughes, Eric A., O'Mara, Edward, Youngberg, Stephen P., Wagner, John A., Butterton, Joan R.
Published in Clinical infectious diseases (01.03.2013)
Published in Clinical infectious diseases (01.03.2013)
Get full text
Journal Article